menu search

Atara biotherapeutics, inc. (atra) q3 2023 earnings call transcript

Atara biotherapeutics, Inc. (NASDAQ:ATRA ) Q3 2023 Results Conference Call November 1, 2023 9:00 AM ET ...

November 4, 2023, 11:45 am

Shareholder investigation: halper sadeh llc investigates slgc, sp, mrtx

NEW YORK, Nov. 04, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...

November 4, 2023, 4:00 am

U.s. ipo weekly recap: biotech lexeo stumbles after $100 million ipo

Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late. As of 11/2/2023, the Renaissance IPO Inde...

November 4, 2023, 12:21 am

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Oncolytics biotech inc. (oncy) q3 2023 earnings call transcript

Oncolytics biotech Inc. (NASDAQ:ONCY ) Q3 2023 Earnings Conference Call November 3, 2023 8:30 AM ET Com...

November 3, 2023, 9:05 pm

Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data

November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Aligos Therapeu...

November 3, 2023, 8:30 pm

Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting

– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...

November 3, 2023, 8:05 pm

Kineta reports third quarter 2023 financial results and provides corporate update

Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial Enrolled the first patient of KVA12123 in comb...

November 3, 2023, 8:01 pm

Taysha gene therapies: tsha-102's potential is a 'buy'

Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS disease...

November 3, 2023, 7:41 pm

Update: korro bio and frequency therapeutics announce closing of merger and private placement of $117 million

Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction cash of approximately $170 million expected to fu...

November 3, 2023, 7:31 pm

Korro bio and frequency therapeutics announce closing of merger and private placement of $117 million

Korro will be focused on advancing a wholly owned portfolio of RNA editing programs Post-transaction cash of approximately $170 million expected to fu...

November 3, 2023, 4:19 pm

Intesa sanpaolo s.p.a. (isnpy) q3 2023 earnings call transcript

Intesa Sanpaolo S.p.A. (OTCPK:ISNPY) Q3 2023 Results Conference Call November 3, 2023 10:00 AM ET Company Participants Carlo Messina - Chief Executive...

November 3, 2023, 2:50 pm

Puma biotech (pbyi) q3 earnings beat, revenues lag estimates

Puma biotech's (PBYI) third-quarter 2023 earnings beat estimates, while revenues miss the same. The com...

November 3, 2023, 1:32 pm

Hrmy vs. regn: which stock should value investors buy now?

Investors with an interest in Medical - biomedical and Genetics stocks have likely encountered both Har...

November 3, 2023, 12:47 pm

biostem technologies closes oversubscribed $2m private placement

POMPANO BEACH, Fla., Nov. 03, 2023 (GLOBE NEWSWIRE) — bioStem Technologies Inc. (OTC: BSEM), a leadin...

November 3, 2023, 12:30 pm

Longeveron to report third quarter 2023 results and provide corporate update on november 10, 2023

MIAMI, Nov. 03, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage ...

November 3, 2023, 12:00 pm

Rapid micro biosystems reports third quarter 2023 financial results

Reports third quarter 2023 total revenue of $6.1 million, representing growth of 30% compared to third quarter 2022 Reaffirms full year 2023 total rev...

November 3, 2023, 11:00 am


Search within

Pages Search Results: